Empirical Finance, LLC United Therapeutics Corp Transaction History

Empirical Finance, LLC

  • $1.86 Billion
  • Q2 2025

A detailed history of Empirical Finance, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Empirical Finance, LLC holds 3,192 shares of UTHR stock, worth $1.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,192
Previous 2,297 38.96%
Holding current value
$1.4 Million
Previous $708,000 29.52%
% of portfolio
0.05%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
BUY
$276.47 - $328.4 $247,440 - $293,918
895 Added 38.96%
3,192 $917,000
Q4 2024

Jan 28, 2025
SELL
$348.66 - $410.0 $723,818 - $851,160
-2,076 Reduced 47.47%
2,297 $810,000
Q3 2024

Nov 06, 2024
BUY
$311.04 - $363.55 $5,598 - $6,543
18 Added 0.41%
4,373 $1.57 Million
Q2 2024

Jul 30, 2024
BUY
$228.26 - $319.04 $73,499 - $102,730
322 Added 7.98%
4,355 $1.39 Million
Q1 2024

May 06, 2024
BUY
$210.76 - $249.51 $3,372 - $3,992
16 Added 0.4%
4,033 $926,000
Q3 2023

Nov 02, 2023
BUY
$211.82 - $248.24 $56,555 - $66,280
267 Added 7.12%
4,017 $907,000
Q2 2023

Jul 27, 2023
BUY
$205.19 - $232.99 $398,478 - $452,466
1,942 Added 107.41%
3,750 $827,000
Q4 2022

Jan 24, 2023
BUY
$205.95 - $280.43 $2,471 - $3,365
12 Added 0.67%
1,808 $503,000
Q3 2022

Nov 04, 2022
BUY
$203.3 - $244.17 $365,126 - $438,529
1,796 New
1,796 $376,000
Q4 2021

Feb 04, 2022
SELL
$184.32 - $216.08 $811,008 - $950,752
-4,400 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$179.86 - $214.88 $968,905 - $1.16 Million
-5,387 Reduced 55.04%
4,400 $812,000
Q2 2021

Aug 10, 2021
SELL
$170.47 - $211.93 $2.1 Million - $2.61 Million
-12,324 Reduced 55.74%
9,787 $1.76 Million
Q3 2020

Oct 28, 2020
SELL
$99.9 - $121.13 $302,896 - $367,266
-3,032 Reduced 12.06%
22,111 $2.23 Million
Q3 2020

Oct 26, 2020
SELL
$99.9 - $121.13 $76,223 - $92,422
-763 Reduced 2.95%
25,143 $2.01 Million
Q2 2020

Jul 20, 2020
SELL
$92.74 - $125.82 $438,474 - $594,876
-4,728 Reduced 18.41%
20,957 $3.14 Million
Q2 2020

Jul 20, 2020
BUY
$92.74 - $125.82 $458,970 - $622,683
4,949 Added 23.62%
25,906 $3.14 Million
Q1 2020

Apr 16, 2020
BUY
$79.39 - $115.35 $312,399 - $453,902
3,935 Added 18.09%
25,685 $2.44 Million
Q4 2019

Jan 27, 2020
SELL
$78.31 - $95.34 $265,705 - $323,488
-3,393 Reduced 13.49%
21,750 $1.92 Million
Q3 2019

Oct 30, 2019
BUY
$74.85 - $85.99 $1.26 Million - $1.45 Million
16,809 Added 201.69%
25,143 $2.01 Million
Q2 2019

Jul 09, 2019
BUY
$76.06 - $120.81 $3,346 - $5,315
44 Added 0.53%
8,334 $651,000
Q1 2019

May 10, 2019
BUY
$107.15 - $126.84 $888,273 - $1.05 Million
8,290 New
8,290 $973,000
Q4 2018

Jan 22, 2019
SELL
$101.4 - $128.73 $2.12 Million - $2.69 Million
-20,867 Closed
0 $0
Q3 2018

Oct 18, 2018
BUY
$113.81 - $129.46 $443,403 - $504,376
3,896 Added 22.96%
20,867 $2.67 Million
Q2 2018

Jul 09, 2018
BUY
$101.14 - $118.31 $877,996 - $1.03 Million
8,681 Added 104.72%
16,971 $1.92 Million
Q1 2018

May 10, 2019
SELL
$107.21 - $151.94 $1.68 Million - $2.38 Million
-15,647 Reduced 65.37%
8,290 $973,000
Q1 2018

Apr 25, 2018
BUY
$107.21 - $151.94 $1.61 Million - $2.29 Million
15,043 Added 169.14%
23,937 $2.69 Million
Q4 2017

Feb 01, 2018
SELL
$118.58 - $151.28 $795,908 - $1.02 Million
-6,712 Reduced 43.01%
8,894 $1.32 Million
Q3 2017

Oct 31, 2017
BUY
$114.6 - $136.81 $136,374 - $162,803
1,190 Added 8.25%
15,606 $1.83 Million
Q2 2017

Aug 10, 2017
BUY
N/A
14,416
14,416 $1.87 Million

Others Institutions Holding UTHR

# of Institutions
747
Shares Held
44.1M
Call Options Held
340K
Put Options Held
318K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $20B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Empirical Finance, LLC Portfolio

Follow Empirical Finance, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Finance, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Finance, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email